Skip to main content
Back

2026 Global healthcare equities outlook: Innovation supports healthcare’s long‑term case

24 March 2026

Steven Slaughter, Lead Portfolio Manager

CJ Sylvester, Portfolio Manager

In 2025, global healthcare equities once again demonstrated their lower volatility profile. Early in the year, global equities experienced a meaningful correction as artificial intelligence (AI)-related stocks sold off and higher-than-expected US tariffs fuelled uncertainty among investors. During this period, healthcare equities proved more resilient, recording a noticeably smaller drawdown than the broader market. Although the sector trailed the rebound of global equities - despite both finishing in positive territory for the full year - we believe that the defensive characteristics of the overall healthcare industry, coupled with remarkable therapeutic innovations in the biopharmaceutical, MedTech, and tools sub-segments of this sector, will continue to be rewarded with capital appreciation over a full market cycle. Current valuations relative to the broader market make for an attractive entry point today, and periods like this tend to lead to outperformance for healthcare stocks over the long term.

Summary:

  • Regulatory and public policy changes were significant overhangs for healthcare in 2025. However, we believe that the passage of time has allowed greater visibility on several mitigating factors.
  • Within the biopharmaceuticals, MedTech and life science tools, and healthcare providers and services industries, we see abundant investment opportunities in 2026.
  • Demographic trends in healthcare, coupled with remarkable therapeutic innovations of this sector, will likely continue to be rewarded with share-price gains over a full market cycle.

 

Download full PDF

  • 2026 Mid-Year Outlook Series: GEDI

    Against a highly uncertain backdrop in the first half of 2026, Manulife’s Global Equity Diversified Income (GEDI) Fund (‘the Fund’) posted resilient performance with relatively lower volatility. This result was driven by the Fund’s four investment pillars, which favour an income-centric approach, coupled with global diversification across growth, value, and income equities. In this 2026 Mid-Year Outlook, Paul Kalogirou, Head of Client Portfolio Management, Asia & Global Multi-Asset Solutions, explains how the Fund’s unique structure allows for consistent income generation and potential upside across the market cycle, while also identifying key opportunities and risks for the second half of the year.

    Read more
  • 2026 Mid-year outlook: Global Semiconductor

    The semiconductor sector remains a key enabler of the global economy, underpinning artificial intelligence (AI), cloud computing, and electrification. As highlighted in our earlier insights, it represents a broad ecosystem supported by structural demand and real infrastructure investment. Following strong year-to-date performance, we see growing conviction that momentum can extend into the second half of 2026 and into 2027, driven by earnings strength, sustained capital investment, and early-stage AI adoption.

    Read more
  • 2026 Mid-year Outlook Series: Diversified Real Assets

    Global supply chains are resetting under deglobalisation and geopolitics, shifting from global efficiency to more expensive regional resilience, embedding higher structural costs. At the same time, artificial intelligence (AI) is emerging as a new demand driver, accelerating investment in power, infrastructure, and materials. Against this backdrop of structurally higher inflation and dual demand pressures – from both supply-chain rewiring and AI capital expenditure – we believe real assets may play an increasingly important role in portfolios, offering exposure to long-term secular growth and AI trends.

    Read more
See all
  • 2026 Mid-Year Outlook Series: GEDI

    Against a highly uncertain backdrop in the first half of 2026, Manulife’s Global Equity Diversified Income (GEDI) Fund (‘the Fund’) posted resilient performance with relatively lower volatility. This result was driven by the Fund’s four investment pillars, which favour an income-centric approach, coupled with global diversification across growth, value, and income equities. In this 2026 Mid-Year Outlook, Paul Kalogirou, Head of Client Portfolio Management, Asia & Global Multi-Asset Solutions, explains how the Fund’s unique structure allows for consistent income generation and potential upside across the market cycle, while also identifying key opportunities and risks for the second half of the year.

    Read more
  • 2026 Mid-year outlook: Global Semiconductor

    The semiconductor sector remains a key enabler of the global economy, underpinning artificial intelligence (AI), cloud computing, and electrification. As highlighted in our earlier insights, it represents a broad ecosystem supported by structural demand and real infrastructure investment. Following strong year-to-date performance, we see growing conviction that momentum can extend into the second half of 2026 and into 2027, driven by earnings strength, sustained capital investment, and early-stage AI adoption.

    Read more
  • 2026 Mid-year Outlook Series: Diversified Real Assets

    Global supply chains are resetting under deglobalisation and geopolitics, shifting from global efficiency to more expensive regional resilience, embedding higher structural costs. At the same time, artificial intelligence (AI) is emerging as a new demand driver, accelerating investment in power, infrastructure, and materials. Against this backdrop of structurally higher inflation and dual demand pressures – from both supply-chain rewiring and AI capital expenditure – we believe real assets may play an increasingly important role in portfolios, offering exposure to long-term secular growth and AI trends.

    Read more
See all
Important notice

With effect from 2 July 2026, the Customer Service Centre of Manulife Investment Management (Hong Kong) Limited is relocated to 23/F., Manulife Tower, One Bay East, 83 Hoi Bun Road, Kwun Tong, Kowloon.  This centre provides customer services in relation to Manulife InvestChoice Accounts, Manulife Advanced Fund SFC, Manulife Global Fund and Manulife Hong Kong Series.  Please call Customer Contact Centre at 2108 1110 to make an appointment prior to your visit.  

View more